US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

71.78

+1.151.63%

Post-market: 70.64-1.1482-1.60%16:10 EDT

Volume:16

Turnover:1K

Market Cap:717.92K

PE:- -

High:71.78

Open:70.64

Low:71.78

Close:70.64

52wk High:85.03

52wk Low:56.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.05

T/O Rate:0.16%

Dividend:2.08

Dividend Rate:2.89%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK Has Limited Margin for Error to Hit 2031 Target

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Market Chatter: GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition

MT Newswires Live

GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition, Bloomberg Reports

MT Newswires Live

GSK Slips Tuesday, Underperforms Market

GSK Launches Six-Part Dollar Bond Sale to Support Nuvalent Acquisition Financing, Bloomberg Reports

MT Newswires Live

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

GSK Slides Friday, Underperforms Market

Adlai Nortye's KRAS Opportunity Further Validated by GSK-Hutchmed Deal, Oppenheimer Says

MT Newswires Live

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

GSK Advances Early-Stage Lung Drug With New Formulation Study

GSK Slips Thursday, Underperforms Market

GSK’s Pediatric Asthma Trial Signals Long-Term Upside in Biologic Market

GSK Names Tina Graves President, General Manager for Canada

GlaxoSmithKline (GSK) Gets a Hold from Deutsche Bank

GSK US President Sells Over 44,000 American Depositary Shares

GSK Says Chronic Hepatitis B Treatment Approved in Japan

MT Newswires Live

GSK Says Jemperli Accepted for Priority Review as Potential Treatment for Rectal Cancer

MT Newswires Live

GSK wins first global approval for hepatitis B functional cure in Japan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/GSKH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":71.7846,"timestamp":1789675200000,"preClose":70.6364,"halted":0,"volume":16,"hourTrading":{"tag":"盘后","latestPrice":70.6364,"preClose":71.7846,"latestTime":"16:10 EDT","volume":6,"amount":430.7076,"timestamp":1789675804131,"change":-1.1482,"changeRate":-0.015995,"amplitude":0},"delay":0,"changeRate":0.01625507528696257,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Not Yet Opened","change":1.1482,"latestTime":"09-17 16:00:00 EDT","open":70.6364,"high":71.7846,"low":71.7846,"amount":1130,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":70.6364,"nav":70.29546,"aum":703024.89546,"dividendRate":0.02893,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":70.6364,"preClose":71.7846,"latestTime":"16:10 EDT","volume":6,"amount":430.7076,"timestamp":1789675804131,"change":-1.1482,"changeRate":-0.015995,"amplitude":0},"volumeRatio":0.046702,"impliedVol":0.2137,"impliedVolPercentile":0.7179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.046702,"shares":10001,"dividePrice":2.0767,"high":71.7846,"amplitude":0,"preClose":70.6364,"low":71.7846,"week52Low":56.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":71.7846,"eps":0,"divideRate":0.02893,"volume":16,"delay":0,"ttmEps":0,"open":70.6364,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":67.0681,"twentyDayClose":73.0903,"sixtyDayClose":73.662},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666853917","title":"GSK Has Limited Margin for Error to Hit 2031 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666853917","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666853917?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:44","pubTimestamp":1788965040,"startTime":"0","endTime":"0","summary":"1443 GMT - GSK needs to manage its base business in a flawless way to hit its 2031 sales target, given that it will take a few years for its drug pipeline to contribute to its top line meaningfully, RBC Capital Markets analysts say in a research note. The U.K. drugmaker's core HIV, general medicines, respiratory and vaccines businesses will face significant competition over the next five years and its drug pipeline remains a \"show-me\" story for now, the analysts say. \"We believe GSK has made oncology the priority area with Blenrep and its [antibody-drug conjugate] portfolio, but we don't see material sales until the end of the decade for these assets,\" the analysts add. RBC starts coverage of GSK with a sector perform recommendation and a target price of 19.75 pounds. Shares rise 0.5% to 18.05 pounds.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4532","GSK","GSKH","BK4585","BK4007","GSK.UK","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","IBBJ","TBXU","MRNY","BBH","JHMH","APXH","PBPH","AZNH","SURI","RSPH","PINK","PTH","SYNB","MEDI","IBRN","WDNA","GDOC","FXH","IEIH","GNOM","PSCH","PJP","GSKH","IBB","FTXH","CURE","SBIO","XPH","BBP","IBBQ","FHLC","NVIB","BIB","CNCR","HRTS","CANC","GNMX","FBT","BME","LFSC","MDTX","MNTL","GPCR","MEDX","LLYX","PBE","PSIL","HYLG","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374792","title":"Market Chatter: GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374792","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374792?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:29","pubTimestamp":1788892163,"startTime":"0","endTime":"0","summary":"GSK  is raising $6.5 billion from a US high-grade debt sale to help refinance bridge funding for its $10.6 billion takeover of Nuvalent, Bloomberg reported, citing people familiar with the matter.The size of the bond sale is about $500 million more than initial talks, the people reportedly told Bloomberg.GSK didn't immediately reply to a request for comment from MT Newswires.Price: 48.69, Change: -1.21, Percent Change: -2.42","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","NUVL","GSK.UK","GSK","BK4007","BK4139","GSKH","BK4585","BK4539","BK4588","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666758374","title":"GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition, Bloomberg Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2666758374","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666758374?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:23","pubTimestamp":1788891829,"startTime":"0","endTime":"0","summary":"Price: 48.70, Change: -1.20, Percent Change: -2.40","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4588","BK4585","GSK.UK","LU1829250122.USD","BK4139","NUVL","BK4007","BK4539","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371340","title":"GSK Slips Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371340?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:06","pubTimestamp":1788883560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  slid 2.23% to GBP17.97 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index  falling 0.10% to 10,811.66.GSK PLC closed 21.28% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 3.1 million, compared to the 50-day average of 7.2 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","GSKH","BK4585","BK4007","GSK","LU1829250122.USD","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373239","title":"GSK Launches Six-Part Dollar Bond Sale to Support Nuvalent Acquisition Financing, Bloomberg Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373239","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373239?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:09","pubTimestamp":1788872950,"startTime":"0","endTime":"0","summary":"GSK Launches Six-Part Dollar Bond Sale to Support Nuvalent Acquisition Financing, Bloomberg Reports","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["US30Y.BOND","US5Y.BOND","BK4585","GSKH","TMF","US12M.BOND","NUVL","US7Y.BOND","TLT","TLTW","BK4007","US2Y.BOND","US10Y.BOND","LU1829250122.USD","BK4532","BK4588","BK4139","BK4539","GSK","US6M.BOND","GSK.UK","US3Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","GPCR","PBPH","HYLG","XPH","HRTS","TBXU","APXH","JHMH","MRNY","JDOC","GNMX","BBH","BBP","MDTX","SURI","LFSC","IBBQ","FBT","IBRN","PSIL","AZNH","GDOC","MEDI","SYNB","BIB","CURE","FTXH","MEDX","LENZ","PBE","PTH","IBBJ","MNTL","FXH","FHLC","LLYX","GNOM","RSPH","BME","NVIB","PINK","PSCH","PJP","GSKH","WDNA","IDNA","CANC","SBIO","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665535183","title":"GSK Slides Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665535183","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665535183?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:09","pubTimestamp":1788538140,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares slipped 1.07% to GBP18.47 Friday, on what proved to be an all-around mediocre trading session for the stock market, with the FTSE 100 Index  holding steady at 10,831.09.GSK PLC closed 19.08% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 3.6 million, compared to the 50-day average of 7.5 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4588","BK4532","GSKH","BK4585","LU1829250122.USD","BK4007","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664135884","title":"Adlai Nortye's KRAS Opportunity Further Validated by GSK-Hutchmed Deal, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664135884","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664135884?lang=en_us&edition=fundamental","pubTime":"2026-09-04 23:09","pubTimestamp":1788534579,"startTime":"0","endTime":"0","summary":"Adlai Nortye  stands to benefit from the GSK -Hutchmed  deal, which validates growing interest in targeted KRAS therapies, Oppenheimer said in a note emailed Friday.Hutchmed said Thursday its unit licensed rights to GSK to develop and commercialize experimental cancer treatment HMPL-A830 outside Greater China.HMPL-A830 is an EGFR-targeted antibody-drug conjugate carrying a KRAS inhibitor payload. The deal highlights increasing interest in targeted approaches that aim to improve the therapeutic index of RAS-pathway inhibition, Oppenheimer analysts said.Adlai Nortye's approach is differentiated, with AN9025 already in the clinic and data expected in H1 2027. AN4035 uses a pan-RAS inhibitor payload with a CEACAM5-targeting antibody, which could provide advantages in breadth, durability, and target selection, the analysts added.The deal should improve \"investor awareness of comparable RAS-focused platforms and reinforce the strategic value embedded within Adlai Nortye's differentiated RAS ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","GSKH","LU2298322129.HKD","BK4512","GSK.UK","LU1861219969.SGD","BK4141","LU1829250122.USD","LU0124384867.USD","LU0724618433.USD","LU1861215975.USD","ONG","BK4585","LU1983260115.SGD","LU1861214812.USD","BK4588","ALN","LU1978683503.SGD","BK4007","IE00BFMHRM44.USD","BK4139","ON","ANL.AU","LU1720051108.HKD","GSK","IE00BD6J9T35.USD","ONX","LU1720051017.SGD","IE00BZ199S13.USD","BK4605","HCM","LU1854104046.USD","LU2133065610.SGD","LU1548497426.USD","ANL","LU1854103824.USD","LU1861220033.SGD","LU2357305700.SGD","BK7104","LU2360107325.USD","LU0348723411.USD","BK4531"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080500","title":"Sector Update: Healthcare Stocks Higher Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080500?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:49","pubTimestamp":1788457760,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Hutchmed  shares jumped 17% after the company said its unit licensed rights to GSK  to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.3%.Ultragenyx Pharmaceutical  shares fell 45% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1236620750.USD","LU0203345920.USD","LU1718418525.SGD","ABBV","IE0004445239.USD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","APGE","LU1989772923.USD","LU0256863811.USD","LU0820561909.HKD","RXL","GSK.UK","RARE","IXJ","LU0432979614.USD","IYH","LU2125909593.SGD","LU0289961442.SGD","LABU","VHT","MEDX","IBB","LU0708994859.HKD","PPH","XBI","FTXH","TRUH","HCM","LU0124676726.USD","GLAM","LU2237443382.USD","PJP","LU0029864427.USD","IE00BJJMRZ35.SGD","LU1496350171.SGD","LU0114720955.EUR","JDOC","LU1244550577.SGD","GSK","GSKH","XLV","BK4137","SBIO","BK4534","LU0128525929.USD","AGNG","HCSG","FHLC","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","SG9999015978.USD","LU1934455277.USD","LU2487616109.SGD","BK7067","LU1267930813.SGD","LU1804176565.USD","IE000WAW04H5.SGD","AZN","LU1201861249.SGD","LU2756315318.SGD","LU0965509010.AUD","LU2896262040.SGD","IE00B4JS1V06.HKD","LU2125909247.SGD","LU1037948897.HKD","LU2237443382.USD","LU0070217475.USD","LU1691799644.USD","LU0545562505.USD","LU1571399168.USD","LU0211331839.USD","BK4592","LU1868837300.USD","LU2592432038.USD","LU0320765992.SGD","LU0109394709.USD","LU2361044949.HKD","LU1989772840.SGD","BIB","BK4550","IE00BLSP4239.USD","LU2362541513.USD","LU0511384066.AUD","LU1291159041.SGD","SG9999001176.SGD","LU2129689605.HKD","LU2265009873.SGD","AZNH","SG9999014906.USD","LU0058720904.USD","LU2468319806.SGD","LU0070302665.USD","CANC","SG9999003800.SGD","IE00B2B36J28.USD","LU2213496289.HKD","IE000MB6IJN5.SGD","ABBV","LU0158827948.USD","LU0823434583.USD","LU0237698245.USD","IE0001KFT4U8.USD","LU1323610961.USD","LU2125154778.USD","LU1093756168.USD","PBE","LU1236620750.USD","LU1941712264.USD","LU1551013425.SGD","LU2505996509.AUD","SG9999014880.SGD","LU0882574055.USD","TMED","LU0689472784.USD","IE0034235303.USD","LU2129689431.USD","NVOC","NVOX","LU0170899867.USD","BK4585","LU1914381329.SGD","LU2746668974.SGD","ONC","LU1023059063.AUD","LU0949170772.SGD","LU0097036916.USD","LU1720051017.SGD","GB00BDT5M118.USD","LU0994945656.USD","SGXZ57979304.SGD","LU0385154629.USD","LU1720051108.HKD","TRUH","SGXZ31699556.SGD","LU2133065610.SGD","BK7511","LU0306806265.USD","LU0471298694.HKD","LU0432979614.USD","688235","IE00BFSS8Q28.SGD","IE0002141913.USD","LU2089283258.USD","IE00B1BXHZ80.USD","IE00B3PB1722.GBP","PJP","LU2430703178.SGD","LU0069063385.USD","IE000F7OJYX1.SGD","VHT","LU2750360997.AUD","BK4505","LU0683600562.USD","OZEM","04332","LU0345770993.USD","THNR","LU2125909593.SGD","LU2491050071.SGD","LU1032955483.USD","IE00BGHQF631.EUR","XLV","LU0354030511.USD","LU1941712348.USD","LU1829250122.USD","PFE","SG9999014898.SGD","IBB","LU0057025933.USD","SG9999014914.USD","LU0211328371.USD","LU2433249047.HKD","LU0353189763.USD","LU1979441026.SGD","IE00BVYPNW00.USD","LU1670627923.USD","IE0004445015.USD","LU0786609619.USD","IE00BZ1G4Q59.USD","TBXU","IE0004445239.USD","BMY","SG9999015952.SGD","LU0787776722.HKD","LU2237438978.USD","LU2063271972.USD","LU2552382132.HKD","LU1551013342.USD","LU1839511570.USD","IE000BZT7R73.USD","IE00B7SZLL34.SGD","SGXZ99366536.SGD","LU2108987350.USD","LU1974910355.USD","LU2324357040.USD","SGXZ81514606.USD","SG9999014575.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","BK4583","LU0353189680.USD","LU0133085943.USD","SG9999014542.SGD","IE00BJLML261.HKD","IE00BSNM7G36.USD","BK0239","LU2271345857.HKD","LLYZ","LU2361045086.USD","LU0256863811.USD","IE00B775H168.HKD","LU0477156953.USD","LU1064131342.USD","LU1066051811.HKD","LU1221951046.USD","LU1623119135.USD","LU2264538146.SGD","LU2087621335.USD","BK4532","LU1267930730.SGD","LU0943347566.SGD","LU0738911758.USD","SG9999014559.SGD","LU2357305700.SGD","LU2089284900.SGD","LU0203201768.USD","LU1366192091.USD","LU1236620834.HKD","GILD","LU0310800379.SGD","LU1059921491.USD","LU0320765646.SGD","LU0234570918.USD","IE00BLSP4452.SGD","LU1929549753.HKD","LU0859254822.USD","LU1145028129.USD","LU1127390331.HKD","LU1868836591.USD","BK4566","BK4559","IE00BFTCPJ56.SGD","LU0198837287.USD","LU2023250843.SGD","BK4533","LU0985320562.USD","SG9999015945.SGD","LU0965509101.SGD","LU2491050154.USD","LU1917777945.USD","LU1778281490.HKD","LU2023251221.USD","LU2596442595.SGD","LU1732799900.SGD","RXL","BBH","PPH","IE00BVYPNV92.GBP","LU2362540622.SGD","LU2430703251.USD","BK4534","LU2456880835.USD","LU0912757837.SGD","SGXZ80539844.SGD","LU1506573853.SGD","LU0210528500.USD","PAWZ","LU0861579265.USD","LU2471134796.USD","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU2471134952.CNY","LU0456855351.SGD","LU0882574139.USD","LU0154236417.USD","LU2237443895.HKD","LU2125154935.USD","LLYX","LU0265550946.USD","LU1670710661.SGD","LU0094547139.USD","LU0795875169.SGD","IE00B42XCP33.USD","LU2746668461.USD","LU0426412945.USD","LU2211815571.USD","LU2089984988.USD","LU1496350171.SGD","LU0114720955.EUR","LU1244550221.USD","AMGN","LU0053666078.USD","LLY","LU1934455194.USD","IE00B4R5TH58.HKD","LU0208291251.USD","LU2471134523.USD","LU0203345920.USD","LU1883839398.USD","SG9999015341.SGD","LU2023250504.SGD","LU1043141396.HKD","CURE","LU0238689110.USD","LU2112291526.USD","WDNA","IE0002270589.USD","LU1066053197.SGD","IE0000B7K699.USD","CSL.AU","IBBQ","LU0553294199.USD","LU0726765562.USD","LU0545039389.USD","BBIO","GSK.UK","LU1935042991.SGD","LU1116320901.HKD","LU1868837136.USD","LU0980610538.SGD","LU0708994859.HKD","IE00BFSS7M15.SGD","LU0661504455.SGD","LU0417517546.SGD","FTXH","LU0320765059.SGD","MEDX","LU0289739343.SGD","IE00BDGV0183.EUR","LU2462157665.USD","LU2357627491.SGD","LU0889566641.SGD","LU1699723380.USD","LU0471298777.SGD","LU0128525929.USD","LU1674673691.USD","GLAM","LU2362541273.HKD","LU1670711123.USD","HRTS","IE00B7KXQ091.USD","LU0106261372.USD","LU1670711040.USD","LU0472753341.HKD","SG9999001440.SGD","IE00BFXG1179.USD","LU1989772923.USD","LU0316494557.USD","LU2237443978.SGD","LU1280957306.USD","SG9999018857.SGD","IE00BN29S564.USD","LU1221951129.SGD","LU1162221912.USD","06160","IXJ","IE00BKDWB100.SGD","LU1121112475.USD","LU0689626769.HKD","SG9999001176.USD","BK7508","LU0267386448.USD","AGNG","LU0985481810.HKD","IE00BKPKM429.USD","LU1934455863.HKD","LU0823434740.USD","LU2236285917.USD","LU1430594728.SGD","LU1267930490.SGD","LU1066051225.USD","LU2750360641.GBP","LU1712237335.SGD","JNJ","LU1032466523.USD","LU1035775433.USD","LU1988902786.USD","LU2087625088.SGD","LU0130517989.USD","LU1894683264.USD","LU0225771236.USD","LU2403377893.USD","IE0009355771.USD","LU2360106947.USD","LU2028103732.USD","LU0158827781.USD","BK4599","IE00BK4W5L77.USD","LU1989771016.USD","LU2552382215.SGD","BK4568","LU2168564149.EUR","LU2417539215.USD","LU0708995401.HKD","NVS","MRK","IYH","IE00BJT1NW94.SGD","SG9999014567.USD","LU1003077747.HKD","LU1629891620.HKD","LU2462591350.SGD","LU2168564495.EUR","LU1035773651.USD","ELIL","LU1228905540.USD","MEDI","LU0345769631.USD","LU0203347892.USD","SG9999011175.SGD","LU0266013472.USD","SG9999018865.SGD","LU0124676726.USD","BK7501","LU0211327993.USD","SG9999015986.USD","LU0225284248.USD","LU0640476718.USD","SG9999017495.SGD","LU0130102774.USD","LU2461242641.AUD","LU0109391861.USD","LU0265550359.USD","LU0234572021.USD","LU0426417589.USD","LU0321505439.SGD","LU0162691827.USD","SG9999015358.SGD","IE00BJJMRX11.SGD","LU1267930573.SGD","LU2237443622.USD","LU1093756325.SGD","LU0792757196.USD","LU2552382058.USD","LU0965509283.SGD","LU0889565916.HKD","LU0320765489.SGD","ILDR","LU2602419157.SGD","LU1983299246.USD","LU1037948541.HKD","LU0203202063.USD","MHIP","LU2129689514.USD","LU0820561818.USD","LU2360032135.SGD","REGN","LU1261432733.SGD","LU0289739699.SGD","IE00B3T34201.USD","LU1894683348.USD","LU0345769128.USD","LU1232071149.USD","GSKH","LU2347655073.USD","IE00B19Z3581.USD","LU0072461881.USD","LU2237443549.SGD","NVOH","LU1732800096.USD","LU0354030438.USD","GDOC","LU1585245621.USD","LLII","LU0795875086.SGD","LU0868494708.USD","IE00BN8TJ469.HKD","LU0310799852.SGD","LU0942090050.USD","LU0289961442.SGD","LU1244550494.USD","LU0225283273.USD","LU1069344957.HKD","SGXZ51526630.SGD","LU1814569148.SGD","LU0029864427.USD","LU1718418525.SGD","BK4516","IE00B1XK9C88.USD","LU0466842654.USD","LU0345770308.USD","LU0868494617.USD","LU1496350502.SGD","LU2756315664.SGD","LU0323591593.USD","IE00BK4W5M84.HKD","IE00BBT3K403.USD","IE00BJJMRY28.SGD","NVO","LU1670710588.SGD","LU2491049909.HKD","LU1057294990.SGD","LU0648001328.SGD","LU1066051498.USD","SG9999002232.USD","JDOC","LU0672654240.SGD","LU1043141123.HKD","SG9999002224.SGD","IE000SO60NU8.SGD","BK4504","BMED","LU1074936037.SGD","LU0823416689.USD","LU1670628061.USD","LU1548497426.USD","LU0079474960.USD","LU2471134879.HKD","LU1228905037.USD","LU1674673428.USD","LU0006306889.USD","GSK","LU2111349929.HKD","LU0820562030.AUD","LU0306807586.USD","LU2168563687.JPY","IHE","LU2237443465.HKD","LU0964807845.USD","LU0098860793.USD","LU1244550577.SGD","LU0061475181.USD","LU0096364046.USD","LU2430703095.HKD","ELIS","BK4578","IE00BKVL7J92.USD","LU2347655156.SGD","LU0256863902.USD","LU1923622614.USD","LU2023250330.USD","LU0210536198.USD","BK4007","FHLC","LU1061106388.HKD","LU1868836914.USD","LU0174119429.USD","LU2361044865.SGD","IE0005OL40V9.USD","LU1069347547.HKD","IE00BWXC8680.SGD","LU0122379950.USD","SG9999013999.USD","BK4139","LU1868836757.USD","LU2168564222.USD","BK4588","LU0321505868.SGD","LU0820561909.HKD","LU1196500208.SGD","LU0965508806.USD","LU2242652126.USD","BK4581","LU1116320737.USD","LU0395794307.EUR","LU2168564065.EUR","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108497","title":"GSK Advances Early-Stage Lung Drug With New Formulation Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108497","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662108497?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:30","pubTimestamp":1787848239,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is running a new early stage trial called “A Phas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-early-stage-lung-drug-with-new-formulation-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-early-stage-lung-drug-with-new-formulation-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSK","BK4532","BK4588","GSK.UK","GSKH","LU1829250122.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662081745","title":"GSK Slips Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662081745","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662081745?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:06","pubTimestamp":1787846760,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  dropped 2.50% to GBP18.52 Thursday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index  falling 0.79% to 10,792.54.GSK PLC closed 18.84% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 3.1 million, compared to the 50-day average of 7.8 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","BK4588","BK4585","GSK.UK","BK4007","GSK","LU1829250122.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745112","title":"GSK’s Pediatric Asthma Trial Signals Long-Term Upside in Biologic Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745112?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:31","pubTimestamp":1787761877,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running a phase 3 study called “A Study of Depemokim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-pediatric-asthma-trial-signals-long-term-upside-in-biologic-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-pediatric-asthma-trial-signals-long-term-upside-in-biologic-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1829250122.USD","BK4007","BK4532","BK4588","GSK.UK","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662716056","title":"GSK Names Tina Graves President, General Manager for Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2662716056","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662716056?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:05","pubTimestamp":1787745915,"startTime":"0","endTime":"0","summary":"GSK names Tina Graves president, general manager for CanadaGSK appointed Tina Graves as President and General Manager for its Canada business.She most recently ran GSK Taiwan as vice president and gen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1D97Sm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4532","BK4588","LU1829250122.USD","GSK","GSK.UK","BK4007","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782777","title":"GlaxoSmithKline (GSK) Gets a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662782777?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:36","pubTimestamp":1787646968,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline today and set a price target of £20.00. According to TipRanks,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-deutsche-bank-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-deutsche-bank-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSKH","BK4532","BK4566","DB","GSK","BK4585","GSK.UK","BK4552","LU1829250122.USD","BK4118","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272115","title":"GSK US President Sells Over 44,000 American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272115","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661272115?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:32","pubTimestamp":1787581945,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK disclosed that Maya Martinez-Davis, its US president and a person discharging manager...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-sells-over-44000-american-depositary-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-sells-over-44000-american-depositary-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK","GSK.UK","AFG","BK4585","BK4007","GSKH","BK4117","BK4532","BK4588","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661229747","title":"GSK Says Chronic Hepatitis B Treatment Approved in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661229747","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661229747?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:06","pubTimestamp":1787558796,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced on Monday that Japan's Ministry of Health, Labor and Welfare has approved the company's drug Hibsago, or bepirovirsen, as a functional cure for  chronic hepatitis B virus infection","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","GSKH","LU1829250122.USD","GSK","BK4532","BK4007","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661522642","title":"GSK Says Jemperli Accepted for Priority Review as Potential Treatment for Rectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661522642","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661522642?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:28","pubTimestamp":1787556522,"startTime":"0","endTime":"0","summary":"GSK's (GSK) Jemperli has been accepted by the US Food and Drug Administration for priority review of its supplemental biologics license application for patients with previously untreated rectal cancer","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","GSKH","BK4007","BK4588","BK4532","GSK.UK","LU1829250122.USD","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661253122","title":"GSK wins first global approval for hepatitis B functional cure in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661253122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661253122?lang=en_us&edition=fundamental","pubTime":"2026-08-24 14:16","pubTimestamp":1787552216,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. Japan’s Ministry of Health, Labour and Welfare has granted the first global approval for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-wins-first-global-approval-for-hepatitis-b-functional-cure-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-wins-first-global-approval-for-hepatitis-b-functional-cure-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSK","BK4532","GSKH","LU1829250122.USD","GSK.UK","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}